Laverock Therapeutics secures Innovate UK award to advance immune effector cell therapeutics program
Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S. London, UK, 30th October 2023 / Sciad Newswire / Laverock Therapeutics, developer of a unique gene silencing platform for the creation of programmable advanced therapies, is pleased to an...
Source: pharmiweb.com